I agree that this site is using cookies. You can find further informations here.
X
Reding, Mark T
173  results:
Search for persons X
?
1

The impact of obesity on chronic pain in patients with haem..:

Joseph, Keerthy ; Cuker, Adam ; Peltier, Skye...
Haemophilia.  30 (2024)  2 - p. 567-570 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prop..:

Reding, Mark T. ; Simpson, Mindy ; Ducore, Jonathan...
Acta Haematologica.  , 2024
Link: https://doi.org/10.1159/..
 
?
3

Three-year outcomes of valoctocogene roxaparvovec gene ther..:

Madan, Bella ; Ozelo, Margareth C. ; Raheja, Priyanka...
Journal of Thrombosis and Haemostasis.  22 (2024)  7 - p. 1880-1893 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Interim analyses of the multinational real‐world prospectiv..:

Reding, Mark T. ; Álvarez‐Román, María Teresa ; Castaman, Giancarlo...
European Journal of Haematology.  112 (2023)  2 - p. 286-295 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Building the foundation for a community-generated national ..:

Tran, Duc Q. ; Benson, Craig C. ; Boice, Judith A....
Expert Review of Hematology.  16 (2023)  sup1 - p. 19-37 , 2023
Link: https://doi.org/10.1080/..
 
?
6

HTRS2023.P2.22 Evaluating the effectiveness and safety of d..:

Reding, Mark T. ; Román, María Teresa Álvarez ; Sanabria, Martin...
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100243 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pål Andrè...
Therapeutic Advances in Hematology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
8

HTRS2023.O8C.2 Eptacog beta efficacy and safety in underwei..:

Rafique, Amina ; Srivastava, Alok ; Abajas, Yasmina...
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100219 , 2023
Link: https://doi.org/10.1016/..
 
?
9

A laparoscopic approach to address massive splenomegaly, sy..:

Bishop, Alexandra A. ; Krohn, Eric ; Vakayil, Victor R....
Clinical Case Reports.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
10

Prophylaxis use of clotting factor replacement products in ..:

Iorio, Alfonso ; Königs, Christoph ; Reding, Mark T....
Haemophilia.  29 (2022)  1 - p. 33-44 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Clinical studies of extended-half-life recombinant FVIII pr..:

Hermans, Cedric ; Reding, Mark T. ; Astermark, Jan..
Critical Reviews in Oncology/Hematology.  174 (2022)  - p. 103678 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Confirmed long‐term safety and efficacy of prophylactic tre..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pal Andre...
Haemophilia.  27 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
13

Decreased Bleeding Rates in Patients with Hemophilia A Swit..:

Mancuso, Maria Elisa ; Reding, Mark T. ; Negrier, Claude...
Thrombosis and Haemostasis.  121 (2021)  8 - p. 1079-1086 , 2021
Link: https://doi.org/10.1055/..
 
?
14

Safety and efficacy of BAY 94–9027, an extended‐half‐life f..:

Santagostino, Elena ; Lalezari, Shadan ; Reding, Mark T....
Haemophilia.  27 (2021)  4 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
15

PERSEPT 3: A phase 3 clinical trial to evaluate the haemost..:

Escobar, Miguel ; Luck, James ; Averianov, Yevhenii...
Haemophilia.  27 (2021)  6 - p. 911-920 , 2021
Link: https://doi.org/10.1111/..
 
1-15